2022
DOI: 10.1007/s11095-022-03439-z
|View full text |Cite
|
Sign up to set email alerts
|

In vitro Dissolution Testing of Rifampicin Powder Formulations For Prediction of Plasma Concentration–Time Profiles After Inhaled Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 43 publications
0
0
0
Order By: Relevance
“…Understanding the dissolution performance of dry powder is essential in the development of inhaled powder formulation as it affects the pharmacokinetic (PK) profile, yet there is no universally accepted method for assessing dissolution of inhaled products. Das et al [8] present the use of an in vitro dissolution study together with modelling to predict plasma concentration-time profiles of inhaled dry powder formulations. This approach can be employed to assist the design of inhaled formulation to achieve the desirable PK profile.…”
mentioning
confidence: 99%
“…Understanding the dissolution performance of dry powder is essential in the development of inhaled powder formulation as it affects the pharmacokinetic (PK) profile, yet there is no universally accepted method for assessing dissolution of inhaled products. Das et al [8] present the use of an in vitro dissolution study together with modelling to predict plasma concentration-time profiles of inhaled dry powder formulations. This approach can be employed to assist the design of inhaled formulation to achieve the desirable PK profile.…”
mentioning
confidence: 99%